Worldwide, there are 300 million patients suffering from asthma. It is estimated that by 2025 this number will be increasing by another 100 million. Each day, 700 patients die from the disease. Almost all of the deaths are avoidable if the asthma was better managed. In the US, the healthcare costs for asthma are increasing and was 56 billion dollars per year.
To address the problems of increasing healthcare costs associated with poor asthma management, FocusStart Respiratory is developing SpirIT; SpirIT is a comprehensive health IT disease management solution composed of a simple add-on inhaler medical device with multiple smart sensors connected to patient and provider software app. This innovation will improve asthma management (for both patient and physician) and outcomes, and thus reduce healthcare costs.